Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in CashChange in Working CapitalChange in Working CapitalExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innate Pharma (IPHA) Exchange Rate Effect (2019 - 2024)

Innate Pharma posted quarterly Exchange Rate Effect of -$539640.7 for Q4 2024, down 23.58% on a QoQ basis from -$436665.9 in Q4 2022.

Innate Pharma (IPHA) has 5 years of Exchange Rate Effect data on file, last reported at -$539640.7 in Q4 2024.

  • For the quarter ending Q4 2024, Exchange Rate Effect changed N/A year-over-year to -$539640.7; the trailing twelve-month figure through Dec 2024 stood at -$1.7 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, up 335.55% from the prior year.
  • Exchange Rate Effect for Q4 2024 stood at -$539640.7, down from -$436665.9 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at -$14319.0 in Q2 2020 and bottomed at -$714928.0 in Q2 2022.
  • The 4-year median for Exchange Rate Effect is -$488153.3 (2022), against an average of -$412075.3.
  • The widest annual swing landed in 2021, when Exchange Rate Effect tumbled 1397.04%; it then increased 20.97% in 2022.
  • A 4-year view of Exchange Rate Effect shows it stood at -$14319.0 in 2020, then tumbled by 3758.78% to -$552538.0 in 2021, then rose by 20.97% to -$436665.9 in 2022, then declined by 23.58% to -$539640.7 in 2024.
  • The last three Exchange Rate Effect figures came in at -$539640.7 (Q4 2024), -$436665.9 (Q4 2022), and -$714928.0 (Q2 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 3.60 Mn
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -2.70 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn -40.30 Mn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn -900,000.00
8 Evaxion A 65.44 Bn 65.42 Bn - -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn -7.06 Mn
10 Innate Pharma 199.64 Mn 199.64 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -539,640.68
Dec 31, 2024 -539,640.68
Dec 31, 2022 -436,665.87
Dec 31, 2022 -436,665.87
Jun 30, 2022 -714,927.98
Jun 30, 2022 -714,927.98
Dec 31, 2021 -552,537.97
Dec 31, 2021 -552,537.97
Jun 30, 2021 -214,360.32
Jun 30, 2021 -214,360.32
Jun 30, 2020 -14,318.98
Jun 30, 2020 -14,318.98
Jun 30, 2019 -3,370.92
Jun 30, 2019 -3,370.92